Adaptive Biotechnologies: 3Q Earnings Snapshot

November 12, 2019 GMT

SEATTLE (AP) _ Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $14 million in its third quarter.

On a per-share basis, the Seattle-based company said it had a loss of 11 cents.

The life-sciences research company posted revenue of $26.1 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $21.9 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT